Related Articles
COMPARISON OF ADHERENT LYMPHOKINE-ACTIVATED KILLER (A-LAK) CELLS GENERATED BY IL-2 AND IL-7 - CELLULAR MODIFICATIONS INDUCED BY IL-7
Antiproliferative effects of interleukin-1 alpha and nitric oxide release in a human ovarian carcinoma cell line
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy in patients with solid tumors
INTERLEUKIN-1 RECEPTOR ANTAGONIST INHIBITS GROWTH MODULATION OF HUMAN TUMOR-CELL LINES BY INTERLEUKIN-1 IN-VITRO
Evaluation of inflammatory cytokines in malignant and benign pleural effusions.